Northway Biotech

Northway Biotechpharma is a flexible contract service provider for biologics, with expertise in the development of biotechnological active pharmaceutical ingredients (APIs) and drug products, as well as GMP-compliant manufacturing. Headquartered in Lithuania, a member of the EU and a rapidly growing biotechnology hub with a nationally funded university system that supports highly educated scientific talent, Northway Biotechpharma offers contract research and development services including mammalian cell line and bacterial strain development, USP and DSP process development, and protein production process optimization and characterization. Northway Biotechpharma has extensive experience in the development of biosimilars, including MABs (monoclonal antibodies). Northway Biotechpharma also provides quality control testing services, with its global team in the United States and Europe proficient in all aspects of the biopharmaceutical value chain, from cell line development to commercial production and sterile filling.